References
1. Barrera M, Atenafu E. Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings. Bone Marrow Transplantation. 2008;42(1):15-21.
2. Di Giuseppe G, Thacker N, Schechter T, Pole JD. Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review.Bone Marrow Transplantation. 2020;55(7):1240-1254.
3. Janicsák H, Ungvari GS, Gazdag G. Psychosocial aspects of hematopoietic stem cell transplantation. World J Transplant.2021;11(7):263-276.
4. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology.2009;18(2):113-127.
5. Byar KL, Eilers JE, Nuss SL. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant. Cancer Nurs.2005;28(2):148-157.
6. Le RQ, Bevans M, Savani BN, et al. Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 2010;16(8):1162-1170.
7. Bevans M. Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematology Am Soc Hematol Educ Program. 2010;2010:248-254.
8. Elwadhi D, Khandelwal SK, Kumar L, Sharma A. Short-Term Impact of Hematopoietic Stem Cell Transplantation on Psychiatric Morbidity and Quality of Life in Hematological Malignancies in Adults. Indian J Psychol Med. 2020;42(1):61-68.
9. Liang H, Pan L, Xie Y, et al. Health-related quality of life in pediatric patients with β-thalassemia major after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2022.
10. Barrera M, Boyd-Pringle LA, Sumbler K, Saunders F. Quality of life and behavioral adjustment after pediatric bone marrow transplantation.Bone Marrow Transplant. 2000;26(4):427-435.
11. Phipps S, Brenner M, Heslop H, Krance R, Jayawardene D, Mulhern R. Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone marrow transplantation. 1995;15(6):829-835.
12. Phipps S, Dunavant M, Garvie PA, Lensing S, Rai SN. Acute health-related quality of life in children undergoing stem cell transplant: I. Descriptive outcomes. Bone Marrow Transplantation.2002;29(5):425-434.
13. Phipps S, Peasant C, Barrera M, Alderfer MA, Huang Q, Vannatta K. Resilience in children undergoing stem cell transplantation: results of a complementary intervention trial. Pediatrics.2012;129(3):e762-770.
14. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival.Journal of clinical epidemiology. 2004;57(6):597-609.
15. Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic malignancies. Blood, The Journal of the American Society of Hematology. 2017;130(15):1699-1705.
16. Abraham IE, Rauscher GH, Patel AA, et al. Structural racism is a mediator of disparities in acute myeloid leukemia outcomes. Blood, The Journal of the American Society of Hematology.2022;139(14):2212-2226.
17. Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123(9):1590-1596.
18. Barker JN, Boughan K, Dahi PB, et al. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Advances. 2019;3(7):939-944.
19. Baker KS, Davies SM, Majhail NS, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant.2009;15(12):1543-1554.
20. Mielcarek M, Gooley T, Martin PJ, et al. Effects of race on survival after stem cell transplantation. Biol Blood Marrow Transplant.2005;11(3):231-239.
21. Eckrich MJ, Ahn KW, Champlin RE, et al. Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Am J Hematol. 2014;89(2):125-129.
22. Ballen KK, Klein JP, Pedersen TL, et al. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant.2012;18(6):903-912.
23. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL™* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity. Ambulatory Pediatrics. 2003;3(6):329-341.
24. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800-812.
25. Zheng DJ, Lu X, Schore RJ, et al. Longitudinal analysis of quality‐of‐life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children’s Oncology Group AALL0932 trial. Cancer. 2018;124(3):571-579.
26. Bureau UC. American Community Survey Data. 2022; https://www.census.gov/programs-surveys/acs/data.html. Accessed June 24, 2022, 2022.
27. Joshua TV, Rizzo JD, Zhang M-J, et al. Access to hematopoietic stem cell transplantation. Cancer. 2010;116(14):3469-3476.
28. Paulson K, Brazauskas R, Khera N, et al. Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.Biology of Blood and Marrow Transplantation.2019;25(10):2086-2090.
29. Parker C, Berkovic D, Ayton D, Zomer E, Liew D, Wei A. Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review. Current Oncology. 2022;29(6):3807-3824.
30. Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and Impact of Financial Hardship among New England Pediatric Stem Cell Transplantation Families. Biology of Blood and Marrow Transplantation. 2015;21(2):312-318.
31. Brown-Iannuzzi JL, Payne BK, Rini C, DuHamel KN, Redd WH. Objective and subjective socioeconomic status and health symptoms in patients following hematopoietic stem cell transplantation.Psycho-Oncology. 2014;23(7):740-748.
32. Rove KO, Edney JC, Brockel MA. Enhanced recovery after surgery in children: Promising, evidence-based multidisciplinary care.Pediatric Anesthesia. 2018;28(6):482-492.
33. Ajarmeh S, Er L, Brin G, Djurdjev O, Dionne JM. The effect of a multidisciplinary care clinic on the outcomes in pediatric chronic kidney disease. Pediatric Nephrology. 2012;27(10):1921-1927.
34. Cantrell MA, Ruble K. Multidisciplinary care in pediatric oncology.Journal of Multidisciplinary Healthcare. 2011;4:171-181.
35. Hashmi S, Carpenter P, Khera N, Tichelli A, Savani BN. Lost in Transition: The Essential Need for Long-Term Follow-Up Clinic for Blood and Marrow Transplantation Survivors. Biology of Blood and Marrow Transplantation. 2015;21(2):225-232.
36. Patzer RE, Paul S, Plantinga L, et al. A Randomized Trial to Reduce Disparities in Referral for Transplant Evaluation. J Am Soc Nephrol. 2017;28(3):935-942.
37. Beattie S, Lebel S, Tay J. The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature. PLoS One. 2013;8(4):e61586.
38. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL™ in pediatric cancer. Cancer. 2002;94(7):2090-2106.
39. Ng VL, Alonso EM, Bucuvalas JC, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr. 2012;160(5):820-826.e823.
40. Nuss SL, Wilson ME. Health-Related Quality of Life Following Hematopoietic Stem Cell Transplant During Childhood. Journal of Pediatric Oncology Nursing. 2007;24(2):106-115.
41. Bhatia M, Kolva E, Cimini L, et al. Health-Related Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease. Biology of Blood and Marrow Transplantation.2015;21(4):666-672.
42. Oberg JA, Bender JG, Morris E, et al. Pediatric allo-SCT for malignant and non-malignant diseases: impact on health-related quality of life outcomes. Bone Marrow Transplantation.2013;48(6):787-793.
43. Gandhi K, Lim E, Davis J, Chen JJ. Racial-ethnic disparities in self-reported health status among US adults adjusted for sociodemographics and multimorbidities, National Health and Nutrition Examination Survey 2011-2014. Ethn Health. 2020;25(1):65-78.
44. Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQL™ Family Impact Module: Preliminary reliability and validity.Health and Quality of Life Outcomes. 2004;2(1):55.
45. Ku E, McCulloch CE, Grimes BA, Johansen KL. Racial and Ethnic Disparities in Survival of Children with ESRD. Journal of the American Society of Nephrology. 2017;28(5):1584.
46. Majhail NS, Nayyar S, Santibañez ME, Murphy EA, Denzen EM. Racial disparities in hematopoietic cell transplantation in the United States.Bone Marrow Transplant. 2012;47(11):1385-1390.
47. Malek SK, Keys BJ, Kumar S, Milford E, Tullius SG. Racial and ethnic disparities in kidney transplantation. Transplant International.2011;24(5):419-424.
48. Warren C, Carpenter A-M, Neal D, Andreoni K, Sarosi G, Zarrinpar A. Racial Disparity in Liver Transplantation Listing. Journal of the American College of Surgeons. 2021;232(4):526-534.